跳至主要内容
临床试验/NCT05047133
NCT05047133招募中2 期

Does Early Administration of Tranexamic Acid Decrease Perioperative Blood Loss in Addition to Intraoperative Tranexamic Acid for Hip Fracture Patients?

Ascension Health1 个研究点 分布在 1 个国家目标入组 170 人开始时间: 2021年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
170
试验地点
1
主要终点
Postoperative Blood Transfusion

研究概览

简要总结

This is a prospective clinical study designed to assess blood loss in intracapsular and extracapsular hip fractures undergoing operative fixation at a Level II trauma center. It is well established in the orthopedic literature that tranexamic acid (TXA) decreases blood loss and need for postoperative blood transfusion in hip fracture patients as well as total joint arthroplasty patients. A typical dosing pattern, and the dosing pattern employed at our institution, is 1 gram IV infused prior to incision followed by 1 gram IV infused at the time of wound closure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All adult (18 years old or older) hip fracture patients presenting with an acute hip fracture and undergoing operative fixation

排除标准

  • Polytrauma patients
  • Previous operation on the ipsilateral hip
  • Patients with coagulopathies (Factor V Leiden, Sickle Cell Anemia, Etc.)
  • Patients with < 6-month history of thromboembolic event (DVT/PE), Stroke, Cardiac Stents, or Myocardial Infarction (MI)
  • History of seizure disorder
  • Patients on birth control
  • Pregnant Women
  • Active thromboembolic disease (DVT/PE, MI, Stroke)

研究组 & 干预措施

Early Adminstration of TXA + Intraoperative TXA

Experimental

This group receives 1 G of TXA as soon as possible after a diagnosis of an acute hip fracture if the patient meets inclusion and exclusion criteria. The group will also receive 2 grams of TXA total intraoperatively.

干预措施: Tranexamic acid (Drug)

Intraoperative only TXA

Other

This group will only receive the intraoperative TXA.

干预措施: Tranexamic acid (Drug)

结局指标

主要结局

Postoperative Blood Transfusion

时间窗: Up to two weeks

Patient receives a blood transfusion during their postoperative stay in the hospital

Overall Blood Loss

时间窗: Up to two weeks

Calculate the difference in postoperative blood loss between groups

次要结局

  • Length of hospital stay(Up to two weeks)
  • Postoperative Pain(Up to two weeks)
  • Wound complications(Up to two weeks)
  • Acute DVT/PE(Up to two weeks)

研究者

申办方类型
Industry
责任方
Principal Investigator
主要研究者

Jacob Hinkley

Resident Physician

Ascension Health

研究点 (1)

Loading locations...

相似试验